Amruta Herbals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-07-2024
- Paid Up Capital ₹ 1.00 M
as on 17-07-2024
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.48 M
as on 17-07-2024
- Revenue -19.37%
(FY 2023)
- Profit -24.70%
(FY 2023)
- Ebitda -19.69%
(FY 2023)
- Net Worth 9.89%
(FY 2023)
- Total Assets 16.90%
(FY 2023)
About Amruta Herbals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹2.48 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vijay Jethani, Cherian Koshy, Pramod Waikar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24233MP2005PTC017832
- Company No.
017832
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jul 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Amruta Herbals Private Limited offer?
Amruta Herbals Private Limited offers a wide range of products and services, including Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Medicinal Plant, Root and Vegetable Extracts, Garlic Extract, Herbs,Sticks and Roots, Ayurvedic & Herbal Extracts, Herbal Extracts, Plant Extracts, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at Amruta Herbals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Jethani  | Whole-Time Director | 28-Jul-2005 | Current |
| Cherian Koshy | Whole-Time Director | 28-Jul-2005 | Current |
| Pramod Waikar | Director | 28-Jul-2005 | Current |
| Achyut Padmawar | Whole-Time Director | 28-Jul-2005 | Current |
| Rajesh Ramanujacharya | Director | 28-Jul-2005 | Current |
Financial Performance of Amruta Herbals.
Amruta Herbals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.37% decrease. The company also saw a substantial fall in profitability, with a 24.7% decrease in profit. The company's net worth moved up by a moderate rise of 9.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amruta Herbals?
In 2022, Amruta Herbals had a promoter holding of 79.90% and a public holding of 20.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ayursatva Herbals Private LimitedActive 16 years 11 monthsVijay Jethani, Cherian Koshy and 3 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 19 Dec 2006 | ₹2.48 M | Satisfied |
How Many Employees Work at Amruta Herbals?
Unlock and access historical data on people associated with Amruta Herbals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amruta Herbals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amruta Herbals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
